View in EDS PDF Full Text

IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.

Saved in:
Bibliographic Details
Title: IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
Authors: Silva BJA; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Krogstad PA; Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, United States., Teles RMB; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Andrade PR; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States., Rajfer J; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Ferrini MG; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Yang OO; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States., Bloom BR; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States., Modlin RL; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Dec 15; Vol. 14, pp. 1284148. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38162653
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Silva+BJA%22">Silva BJA</searchLink>; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Krogstad+PA%22">Krogstad PA</searchLink>; Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Teles+RMB%22">Teles RMB</searchLink>; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Andrade+PR%22">Andrade PR</searchLink>; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Rajfer+J%22">Rajfer J</searchLink>; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ferrini+MG%22">Ferrini MG</searchLink>; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yang+OO%22">Yang OO</searchLink>; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bloom+BR%22">Bloom BR</searchLink>; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Modlin+RL%22">Modlin RL</searchLink>; Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.; Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Dec 15; Vol. 14, pp. 1284148. <i>Date of Electronic Publication: </i>2023 Dec 15 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38162653
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1284148
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1284148
    Titles:
      – TitleFull: IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Silva BJA
      – PersonEntity:
          Name:
            NameFull: Krogstad PA
      – PersonEntity:
          Name:
            NameFull: Teles RMB
      – PersonEntity:
          Name:
            NameFull: Andrade PR
      – PersonEntity:
          Name:
            NameFull: Rajfer J
      – PersonEntity:
          Name:
            NameFull: Ferrini MG
      – PersonEntity:
          Name:
            NameFull: Yang OO
      – PersonEntity:
          Name:
            NameFull: Bloom BR
      – PersonEntity:
          Name:
            NameFull: Modlin RL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 2023 Dec 15
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1